SurrogateBMA (Q5977130)

From MaRDI portal
Revision as of 20:10, 12 March 2024 by Import240312060351 (talk | contribs) (Added link to MaRDI item.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Flexible Evaluation of Surrogate Markers with Bayesian Model Averaging
Language Label Description Also known as
English
SurrogateBMA
Flexible Evaluation of Surrogate Markers with Bayesian Model Averaging

    Statements

    0 references
    Provides functions to estimate the proportion of treatment effect explained by the surrogate marker using a Bayesian Model Averaging approach. Duan and Parast (2023) <doi:10.1002/sim.9986>.
    0 references
    1 February 2024
    0 references
    1.0
    1 February 2024
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references